Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Primary Central Nervous System Lymphoma: Treatment and Nursing Management of Immunocompetent Patients

Kurt David
Mary Elizabeth Davis
CJON 2021, 25(4), 439-448 DOI: 10.1188/21.CJON.439-448

Background: Primary central nervous system lymphoma (PCNSL) is a rare primary brain tumor. Because of its rarity and the increasing incidence rates as the U.S. population ages, it is important for nurses to understand the unique needs of patients and their caregivers during the disease continuum.

Objectives: This article provides an overview of the treatment and nursing management of immunocompetent patients with PCNSL.

Methods: An extensive examination of the current literature, including incidence, diagnosis, treatment, and implications for nursing, was performed.

Findings: Nurses play a vital role in caring for patients with PCNSL and addressing their unique needs. Nurses should concentrate on early recognition and comprehensive management of neurologic symptoms. This includes patient and caregiver education and diligent implementation of treatment strategies, as well as maximizing quality of life.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or